160 related articles for article (PubMed ID: 31708464)
21. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
[TBL] [Abstract][Full Text] [Related]
22. TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma.
Li X; Cheng R
Sci Rep; 2023 Jul; 13(1):10848. PubMed ID: 37407700
[TBL] [Abstract][Full Text] [Related]
23. Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer.
Machens A; Dralle H
J Clin Endocrinol Metab; 2012 Dec; 97(12):4375-82. PubMed ID: 23019347
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
25. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
27. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
28. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
29. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
30. Predictive Value of BRAF
Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
[TBL] [Abstract][Full Text] [Related]
32. Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.
Haglund F; Garvin S; Ihre-Lundgren C; Nilsson IL; Hall E; Carling T; Höög A; Juhlin CC
Endocr Pathol; 2016 Dec; 27(4):346-351. PubMed ID: 27251056
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
[TBL] [Abstract][Full Text] [Related]
34. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
35. LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.
Pinheiro Dos Santos MJC; Bastos AU; da Costa VR; Delcelo R; Lindsey SC; Colozza-Gama GA; Peng H; Rauscher FJ; Oler G; Cerutti JM
Endocr Pathol; 2018 Sep; 29(3):222-230. PubMed ID: 29560564
[TBL] [Abstract][Full Text] [Related]
36. Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound Analysis in Preoperative Diagnosis of Cervical Lymph Node Metastasis From Papillary Thyroid Carcinoma.
Chen L; Chen L; Liu J; Wang B; Zhang H
J Ultrasound Med; 2020 Jan; 39(1):73-81. PubMed ID: 31222782
[TBL] [Abstract][Full Text] [Related]
37. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
38. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
39. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis.
Musholt TJ; Staubitz JI; Antonio Cámara RJ; Musholt PB; Humberg D; Springer E; Schad A
Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]